These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states. Thamer M; Richard C; Ray NF; Greer JW; Cotter DJ; Pearson BC Am J Kidney Dis; 1996 Aug; 28(2):235-49. PubMed ID: 8768919 [TBL] [Abstract][Full Text] [Related]
4. Association of race with cumulative exposure to statins in dialysis. Wetmore JB; Mahnken JD; Rigler SK; Ellerbeck EF; Mukhopadhyay P; Hou Q; Shireman TI Am J Nephrol; 2012; 36(1):90-6. PubMed ID: 22739257 [TBL] [Abstract][Full Text] [Related]
5. HMG-coenzyme a reductase inhibitor use is associated with mortality reduction in hemodialysis patients. Mason NA; Bailie GR; Satayathum S; Bragg-Gresham JL; Akiba T; Akizawa T; Combe C; Rayner HC; Saito A; Gillespie BW; Young EW Am J Kidney Dis; 2005 Jan; 45(1):119-26. PubMed ID: 15696451 [TBL] [Abstract][Full Text] [Related]
6. Impact of race on cumulative exposure to antihypertensive medications in dialysis. Wetmore JB; Mahnken JD; Rigler SK; Ellerbeck EF; Mukhopadhyay P; Hou Q; Shireman TI Am J Hypertens; 2013 Feb; 26(2):234-42. PubMed ID: 23382408 [TBL] [Abstract][Full Text] [Related]
7. Statin use among Veterans with dialysis-dependent chronic kidney disease. Markossian TW; Kramer HJ; Burge NJ; Pacold IV; Leehey DJ; Huo Z; Schneider J; Ling B; Stroupe KT Hemodial Int; 2019 Apr; 23(2):206-213. PubMed ID: 30779455 [TBL] [Abstract][Full Text] [Related]
8. Geographic Variation of Statin Use Among US Nursing Home Residents With Life-limiting Illness. Mack DS; Baek J; Tjia J; Lapane KL Med Care; 2021 May; 59(5):425-436. PubMed ID: 33560713 [TBL] [Abstract][Full Text] [Related]
9. Prevalent Statin Use in Long-Stay Nursing Home Residents with Life-Limiting Illness. Mack DS; Tjia J; Hume AL; Lapane KL J Am Geriatr Soc; 2020 Apr; 68(4):708-716. PubMed ID: 32057091 [TBL] [Abstract][Full Text] [Related]
10. HMG-CoA reductase inhibitors are associated with reduced mortality in ESRD patients. Seliger SL; Weiss NS; Gillen DL; Kestenbaum B; Ball A; Sherrard DJ; Stehman-Breen CO Kidney Int; 2002 Jan; 61(1):297-304. PubMed ID: 11786112 [TBL] [Abstract][Full Text] [Related]
11. Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease. Ho LT; Lin LY; Yang YH; Wu CK; Juang JM; Wang YC; Tsai CT; Lai LP; Hwang JJ; Chiang FT; Lin JL; Chen PC Int J Cardiol; 2015 Dec; 201():538-43. PubMed ID: 26322603 [TBL] [Abstract][Full Text] [Related]
12. Association of Continuation of Statin Therapy Initiated Before Transition to Chronic Dialysis Therapy With Mortality After Dialysis Initiation. Streja E; Gosmanova EO; Molnar MZ; Soohoo M; Moradi H; Potukuchi PK; Kalantar-Zadeh K; Kovesdy CP JAMA Netw Open; 2018 Oct; 1(6):e182311. PubMed ID: 30646217 [TBL] [Abstract][Full Text] [Related]
13. Medication use among dialysis patients in the DMMS. United States Renal Data System. Dialysis Morbidity and Mortality Study. Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S60-8. PubMed ID: 9713408 [No Abstract] [Full Text] [Related]
14. Comorbidity ascertainment from the ESRD Medical Evidence Report and Medicare claims around dialysis initiation: a comparison using US Renal Data System data. Krishnan M; Weinhandl ED; Jackson S; Gilbertson DT; Lacson E Am J Kidney Dis; 2015 Nov; 66(5):802-12. PubMed ID: 26015277 [TBL] [Abstract][Full Text] [Related]
15. The Healthy People 2020 Objectives for Kidney Disease: How Far Have We Come, and Where Do We Need to Go? Wetmore JB; Liu J; Li S; Hu Y; Peng Y; Gilbertson DT; Collins AJ Clin J Am Soc Nephrol; 2017 Jan; 12(1):200-209. PubMed ID: 27577245 [TBL] [Abstract][Full Text] [Related]
16. For-profit versus not-for-profit dialysis care for children with end stage renal disease. Furth SL; Hwang W; Neu AM; Fivush BA; Powe NR Pediatrics; 1999 Sep; 104(3 Pt 1):519-24. PubMed ID: 10469779 [TBL] [Abstract][Full Text] [Related]
17. Race, ethnicity, and state-by-state geographic variation in hemorrhagic stroke in dialysis patients. Wetmore JB; Phadnis MA; Mahnken JD; Ellerbeck EF; Rigler SK; Zhou X; Shireman TI Clin J Am Soc Nephrol; 2014 Apr; 9(4):756-63. PubMed ID: 24458073 [TBL] [Abstract][Full Text] [Related]
18. HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. Wang PS; Solomon DH; Mogun H; Avorn J JAMA; 2000 Jun; 283(24):3211-6. PubMed ID: 10866868 [TBL] [Abstract][Full Text] [Related]
19. Effect of insurance on prescription drug use by ESRD beneficiaries. Shih YC Health Care Financ Rev; 1999; 20(3):39-54. PubMed ID: 10558019 [TBL] [Abstract][Full Text] [Related]
20. The prevalence of and factors associated with chronic atrial fibrillation in Medicare/Medicaid-eligible dialysis patients. Wetmore JB; Mahnken JD; Rigler SK; Ellerbeck EF; Mukhopadhyay P; Spertus JA; Hou Q; Shireman TI Kidney Int; 2012 Mar; 81(5):469-76. PubMed ID: 22189842 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]